Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
108.5 USD | +1.11% | +3.75% | -0.97% |
Apr. 30 | TD Cowen Adjusts Price Target on Revvity to $130 From $123 | MT |
Apr. 30 | JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.97% | 13.24B | |
+12.76% | 229B | |
+14.24% | 195B | |
+17.91% | 142B | |
+29.12% | 109B | |
+3.27% | 64.85B | |
+18.41% | 54.33B | |
+7.63% | 52.09B | |
+11.07% | 45.15B | |
+5.76% | 37.39B |
- Stock Market
- Equities
- RVTY Stock
- News Revvity, Inc.
- Nephron Adjusts Revvity's Price Target to $124 From $120